<DOC>
	<DOCNO>NCT03081442</DOCNO>
	<brief_summary>Groups study : 120 candidate Cu T 380A IUD insertion enrol study . They divide two group : Group 1 : Sixty woman receive 600 microgram misoprostol vaginally deep possible six hour IUD insertion . Group 2 : Sixty woman receive placebo vaginally . The placebo misoprostol put 120 numbered close envelope accord table random number envelope allocate patient accordingly . Methodology : All patient subject follow : ( ) Complete history taking ( ii ) Proper counseling : ( iv ) Examination : ( v ) 600ug misoprostol ( 3tablets Misotac® , ( Sigma Pharmaceutical Industries , Egypt ) placebo administer Vaginally deep possible 6 hour insertion IUD gynecologist . ( vi ) Insertion IUD : ( TCu-380A® , Pregna International Ltd , India ) After full history take , Proper counseling , Informed consent take patient , examination ( general , abdominal pelvic ) exclude pathology . A careful bimanual examination do prior IUD insertion . The cervix expose introduce vaginal speculum , cervix vaginal vault clean povidone- iodine solution . The Next step sound measure depth uterus . The IUD fold insertion tube immediately prior insertion . The cervix grasp tenaculum , gently pull downward straighten angle flection . The insertion tube advance uterus correct depth mark tube slide plastic flange . The out sheath insert withdrawn short distance release arm T gently push inward elevate open T fundus uterus . The inserter tube remove . Then string cut project 2-4 cm external cervical o .</brief_summary>
	<brief_title>Vaginal Misoprostol Before IUD Insertion Women With Cesarean Scar</brief_title>
	<detailed_description>Groups study : 120 candidate Cu T 380A IUD insertion enrol study . They divide two group : Group 1 : Sixty woman receive 600 microgram misoprostol vaginally deep possible six hour IUD insertion . Group 2 : Sixty woman receive placebo vaginally . The placebo misoprostol put 120 numbered close envelope accord table random number envelope allocate patient accordingly . Methods randomization : To insure everyone equal chance participation , randomization guide table random number use computer generate system ( SPSS : windous version8 ) ( SPSS Inc. , Chicago , USA ) double blinding technique use thus ; investigator patient n't know group patient allocate . Methodology : All patient subject follow : ( ) Complete history taking : - Full history take . - Obstetric history . - Menstrual history . - Medical history . Data collect special form patient . ( ii ) Proper counseling : Proper counsel patient different type IUDs , advantage side effect type , explanation menstrual pattern change , assure patient change common disappear period time insertion . ( iii ) Consent : Informed consent take patient . ( iv ) Examination : 1 . General examination . 2 . Abdominal examination . 3 . Pelvic examination exclude pelvic pathology . ( v ) 600ug misoprostol ( 3tablets Misotac® , ( Sigma Pharmaceutical Industries , Egypt ) placebo ( stugeron® , Mina Pharm . licence Janssen Pharmaceutica , Egypt ) administer Vaginally deep possible 6 hour insertion IUD gynecologist . ( vi ) Insertion IUD : ( TCu-380A® , Pregna International Ltd , India ) After full history take , Proper counseling , Informed consent take patient , examination ( general , abdominal pelvic ) exclude pathology . A careful bimanual examination do prior IUD insertion . The cervix expose introduce vaginal speculum , cervix vaginal vault clean povidone- iodine solution . The Next step sound measure depth uterus . The IUD fold insertion tube immediately prior insertion . The cervix grasp tenaculum , gently pull downward straighten angle flection . The insertion tube advance uterus correct depth mark tube slide plastic flange . The out sheath insert withdrawn ashort distance release arm T gently push inward elevate open T fundus uterus . The inserter tube remove . Then string cut project 2-4 cm external cervical o . Post insertion instruction : Palpation string perform monthly patient verify continue presence IUD menstrual flow . Caution patient first 2 menses typically heavy .</detailed_description>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Women previous cesarean section previous vaginal delivery attend outpatient clinic IUD insertion 1. contraindication misoprostol use ( pregnancy prostaglandin allergy ) . 2. contraindication IUD use ( gynecologic malignancy , pelvic inflammatory disease unexplained vaginal bleeding ) . 3. previous vaginal delivery . And ( 4 ) medical disorder diabetes , hypertension bleeding tendency .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>